← Back

Wire · opportunities

AHA Recommends FDA Permanently Adopt CDS Flexibilities, Clarify 'General Wellness' Policy

Published

15 August 2026

Topic

opportunities

Sectors

Medtech

Geography

United States

Source

Read at insidehealthpolicy.com

Verified

Fusion42 · 15 August 2026 · Fusion42 review

The American Hospital Association recommends the FDA permanently maintain some Clinical Decision Support (CDS) flexibilities, clarify its 'general wellness' policy for low-risk devices, and update guidance to address new AI applications including generative AI.

This Wire brief sits within Fusion42's coverage of Medtech.

◆ The Wire takeaway

You must anticipate ongoing FDA flexibility on clinical decision software and seek clarity on device classifications as AI uses grow. This opens the door to faster US market entry if you adapt your medtech products to evolving rules now.

Coverage

1 source · 15 Aug 2026

Related on Wire

Topics

Medtechfdaclinical-decision-supportmedical-devicesai-regulationgenerative-ai